A phase II trial of ORY-2001 in Alzheimer's disease patients
Phase of Trial: Phase II
Latest Information Update: 25 Jan 2017
At a glance
- Drugs ORY 2001 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 25 Jan 2017 According to Oryzon media release, this trial is expected to proceed in 2H of 2017.
- 06 Apr 2016 New trial record
- 04 Apr 2016 According to an Oryzon Genomics media release, the company plans to initiate this trial in 1H 2017.